Cue biopharma announces publication in the journal of clinical investigation highlighting immuno-stat biologics for the treatment of chronic infectious diseases

Research demonstrates immuno-stat™ biologics lead to direct and selective activation and expansion of anti-viral cytotoxic t cells in vivo specific for human immunodeficiency virus (hiv) and cytomegalovirus (cmv) highlighting potential as immunotherapeutics for a variety of chronic infectious diseases research demonstrates immuno-stat™ biologics lead to direct and selective activation and expansion of anti-viral cytotoxic t cells in vivo specific for human immunodeficiency virus (hiv) and cytomegalovirus (cmv) highlighting potential as immunotherapeutics for a variety of chronic infectious diseases
CUE Ratings Summary
CUE Quant Ranking